Immune to Cancer: The CRI Blog




Jenny’s Immunotherapy Story


There’s life during cancer, too. Especially when I was doing immunotherapy.

Jenny’s Story

Jenny was still in college when she learned she had advanced Hodgkin lymphoma. Her mother researched immunotherapy clinical trial options and helped Jenny become her own patient advocate. She enrolled in a trial testing a combination of the anti-PD-1 checkpoint inhibitor nivolumab (Opdivo®) along with the antibody-drug conjugate brentuximab vedotin (Adcentris®).

Kris Inman, Caregiver: Going home from the oncologist that day, we were shocked and frightened. The best defense against fear is knowledge and action.

Read more:

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.